Member Info for The.Italian

morning ollie. the response i had was on 3rd of october.i haven't tried since though.yes nice to able to say regent is my top performer today so far but very low volume as usual

many thanks for that.that is very clear and does now ring a faint bell.i did think that uk was not really part of he commercial equation and glad to have the position clarified thanks

small uncrossing trade at 30p after two PMEs.not necessarily significant but may herald a small rise tomorrow.

alquemie forgive my ignorance but what is a CCG and in what way are they backlisting fortacin and for what reason?sorry if you have already posted this information but i do not recollect it (old age i expect)

have to agree entirely with point1) in your post.i took the directors subscription to be mildly encouraging as although the amounts were very modest it was a director purchase but i felt it also clearly indicated the there was unlikely to be any contract news or similar for a period probably several weeks.could be wrong and something does get announced but think middle to late december is more likely.just a guess and aimo

I'm pretty sure that mention has been made recently on here of a uk "re-launch" being imminent.i think that was the phraseology used but i cannot now find the post or any official reference to it so may be wrong.if anyone can elaborate it would be appreciated thanks

1.03p paid on ask.very small trade though.still trend is for small upticks

not surprised by runs.sensible step on part of company but of no comfort or help to pi seeking further information.i expect the BOD have been told very firmly not to give out any information.it will be interesting to see if anything new emerges despite this.

and me

strong performance so far today.hopefully indicates confidence moving towards results next week

i agree with strider4s post from 8.34 this morning.whilst it cannot be ruled out entirely i cannot personally see mtfb going it alone.simply too expensive and they will imo wish to ensure some form of revenue receipts asap after FDA approval by way of development payments /milestones from whoever they go with.agree also that the apparent internal inactivity re recruitment etc would strongly indicate imo that this is the intention.what will be crucial will be the terms of the partnership/licencing agreement which will reflect the respective parties bargaining strengths .we can only guess at these and not much point imo speculating on the possibilities at the moment but again just in my opinion even if the major bargaining strength lies with the partner/licensee we should still see a very significant re rating of the s/p

ok jez no more comments from me.i will leave you with final word and hope that s/p picks up for all of you

we are pretty much at a 12 month low i think so my worry (one of them at least) is that if there are behind the scenes machinations any resulting t/o offer or purchase price of fortacin would be based on such a low m/c that many of us i suspect would not return to profit.100% premium to todays price only puts us back to 46 cents or so.some of us might be quite happy with that after the last few months but I'm hoping for a reasonable s/p recovery first before any news of t/o etc .sadly no indication of this as yet just musing and my opinion only.

jeez you are confusing responsibility for the share price with responsibility for investors decisions .they are not the same.i have personally never been influenced by any of your posts but suspect that there are some who have been.they should not have done so be when you couch your posts in terms of some superior and at times omniscient investment knowledge and expertise you must have some expectation that it will influence others. that is my point.amused at the description of whining lefties.somewhat wide of the mark I'm afraid! .

agree with all you say.im a former holder in mysq.lost money but sold out some time ago sorry for those who have remained and lost more.irresponsible posting by the likes of jez carries some responsibility as although he should obviously just be ignored it can be difficult to do so in practice.

level 2 suggests will open at 29.5p on the bid so looking like normal service despite the obviously tendentious posting by some this morning .perfectly normal and sensible to participate in conferences regardless of what may be going on in other areas.fundamental investment case remains positive and unchanged.aimo

i don't think so sider.the count shows 11 posts which there are.could be wrong of course.

ok thats interesting.thank you for that

thanks for that.does the fact that fortacin is listed second to last in list of other corporate products indicate it was the second to last contributor?the list does not appear to be alphabetical but may have some other basis not apparent to my non pharma brain.wouldnt be surprising if it is almost last particularly as list covers 9 month period

couldn't agree more FLT2017.sensible and interesting post if i may say so.